The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
AdaptHealth Corp (NASDAQ: AHCO) closed the day trading at $9.53 down -5.83% from the previous closing price of $10.12. In other words, the price has decreased by -$5.83 from its previous closing price. On the day, 2.04 million shares were traded. AHCO stock price reached its highest trading level at $10.191 during the session, while it also had its lowest trading level at $9.41.
Ratios:
For a better understanding of AHCO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.45. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.
On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.
Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 19 ’24 when Rietkerk Shaw bought 32,500 shares for $9.70 per share.
Clemens Jason A sold 35,000 shares of AHCO for $327,250 on Dec 10 ’24. The Chief Financial Officer now owns 420,719 shares after completing the transaction at $9.35 per share. On Dec 10 ’24, another insider, JASON A CLEMENS &BIANCA S VITA, who serves as the Officer of the company, bought 35,000 shares for $9.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1285282560 and an Enterprise Value of 3309947648. As of this moment, AdaptHealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.76, and their Forward P/E ratio for the next fiscal year is 7.84. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.24. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 0.82. Its current Enterprise Value per Revenue stands at 1.015 whereas that against EBITDA is 4.934.
Stock Price History:
The Beta on a monthly basis for AHCO is 1.48, which has changed by -0.061083734 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, AHCO has reached a high of $11.90, while it has fallen to a 52-week low of $8.35. The 50-Day Moving Average of the stock is -4.69%, while the 200-Day Moving Average is calculated to be -7.51%.
Shares Statistics:
Over the past 3-months, AHCO traded about 1.54M shares per day on average, while over the past 10 days, AHCO traded about 1820340 shares per day. A total of 134.60M shares are outstanding, with a floating share count of 86.49M. Insiders hold about 35.87% of the company’s shares, while institutions hold 73.61% stake in the company. Shares short for AHCO as of 1740700800 were 9421700 with a Short Ratio of 6.13, compared to 1738281600 on 8240239. Therefore, it implies a Short% of Shares Outstanding of 9421700 and a Short% of Float of 9.13.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
